Injectable Steroids

Trenbolone Acetate 100mg

Trenbolone Acetate 100mg (100 mg) — No other anabolic compound approaches the raw potency of Trenbolone Acetate. Its unique ability to simultaneously build lean tissu...

45,00

In Stock (100 available)

Biopharma · Trenbolone Acetate 100mg (100 mg) — No other anabolic compound approaches the raw potency of Trenbolone Acetate. Its unique ability to simultaneously build lean tissu…

100 in stock

This product is for laboratory research use only. Not for human consumption.

5+ −10%
10+ −15% Best price
Third-Party Lab Report HPLC verified
CoA available on request — email support@vitalquests.org with the batch code from your vial.
HPLC TestedBatch report available
No Labels on BoxPlain brown parcel
Pay the CourierCash on delivery only
Ships TodayOrder before 14:00
€85+ = free shipping
EU warehouse — no customs, no delays
Tracked via DHL / DPD / InPost

Description

Trenbolone Acetate, the manufacturer, 100 mg. Short-ester tren for users who want dose-control. Cycle length 6–10 weeks; start at 200 mg/week to assess tolerance before increasing. Cabergoline on hand for prolactin management.

Key Benefits

  • Most potent AR agonist in common use — ~5× testosterone affinity
  • No aromatisation — zero oestrogen conversion, no water retention
  • Dramatic nutrient-partitioning — recomp on maintenance calories
  • Progestagenic — cabergoline for prolactin control
  • Short ester — fast onset, fast exit, EOD pinning minimum
  • Each unit dosed at 100 mg — see Recommended Dosage below for protocol-specific intake

Recommended Dosage

Research dosing: 50–100 mg every other day (150–350 mg/week effective). First-time tren users start at 50 mg EOD for 2 weeks to gauge tolerance. Cycles 8–10 weeks — the compound does not reward longer runs.

How It Works

19-nor derivative with C9 and C11 double-bond additions conferring extreme androgen-receptor affinity. Does not aromatise. Moderately progestagenic — raises prolactin in some users. Potent nutrient-partitioning effect: simultaneous lean-mass accrual and fat loss at maintenance calories.

Pharmacokinetics

Plasma half-life approximately 1 day (acetate ester). EOD minimum pinning; daily smoother. Rapid onset within days, rapid clearance (2 weeks). Short cycle tail makes PCT timing straightforward: start 3 days post-last-pin.

Potential Side Effects

Signature side-effects: night sweats, insomnia, aggression, cardiovascular stress, “tren cough” at injection. Not hepatotoxic but raises creatinine. Cabergoline 0.25 mg 2×/week for prolactin. HDL crashes. Not for beginners or anyone cardiovascular-risk.

Cycle & Stacking Guide

Advanced cutting or recomp, 8–10 weeks. Standard stack: test 200–300 mg/week + tren ace 200–300 mg/week + masteron or winstrol. Not a first cycle. Monitor resting HR, BP, and sleep quality throughout.

Storage & Handling

Store upright at 15–25 °C in the original box, protected from light and moisture. Oil-based injectables are shelf-stable for the duration printed on the vial when kept at controlled room temperature. Do not refrigerate — cold thickens the carrier oil and makes drawing/injecting harder. Keep out of reach of children. For research and educational purposes only.

Reviews

There are no reviews yet.

Be the first to review “Trenbolone Acetate 100mg”

Your email address will not be published. Required fields are marked *

Trenbolone Acetate

Physical & Chemical Properties for Research Purposes
Chemical structure of Trenbolone Acetate (C20H24O3) for laboratory analysis
2D structural representation · PubChem CID 24822 ↗
Chemical Identity
# CAS Registry Number 10161-34-9
Σ IUPAC Name [(8S,13S,14S,17S)-13-methyl-3-oxo-2,3,6,7,8,14-hexahydro-1H-cyclopenta[a]phenanthrene-17-yl] acetate
F Molecular Formula C20H24O3
M Molecular Weight 312.41 g/mol
SMILES CC(=O)O[C@@H]1CC[C@@H]2C3=CC=C4CC(=O)CC[C@]4(C)[C@@H]3CC[C@]12C
InChIKey FNYKCQMZFXUVMA-LKBHZCJUSA-N
Melting Point 96-97 °C
Solubility Practically insoluble in water; soluble in oils and organic solvents
Biological Half-life 1 day (IM)
PubChem CID 24822 ↗
Pharmacological Profile
Anabolic Rating 500
Androgenic Rating 500
Aromatization None
Hepatotoxicity Low
Detection Time 5 months

Clinical Notes

19-nor 5alpha-reduced analogue of nandrolone. Non-aromatizable — AR-binding affinity roughly 5x testosterone, with measurable agonist activity at the progesterone receptor. The acetate ester generates fast serum peaks and drops; EOD administration is the floor for stable concentrations. Clinical picture: rapid lean-tissue accretion independent of caloric surplus, reduced adipose mass via direct AR signalling in adipocytes, pronounced lipid shift (HDL suppression 40–60%). Prolactin elevation occurs in a subset — cabergoline 0.25 mg twice weekly is the standard response. Renal biomarkers (creatinine, cystatin C) commonly shift upward; this reflects haem metabolite excretion in urine (brick-red pigment) rather than confirmed nephrotoxicity, but CKD-EPI readings should be interpreted with the confounding documented. Nocturnal sympathetic tone (insomnia, diaphoresis) is dose-dependent and resolves on cessation.

Known trade names: Finajet, Finaplix, Trenbol

Data sourced from published pharmacological literature and authoritative chemical databases (PubChem, DrugBank, ChEBI). Provided for identification and research reference only.